← back to search

Rosalind A. Segal

Harvard University · US
Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Nerve injury and regeneration, Hedgehog Signaling Pathway Studies, Glioma Diagnosis and Treatment, and Neurogenesis and neuroplasticity mechanisms.
h-index
58
citations
17,063
works
192
NIH funding
primary concept
Biology
email

Recent publications

Satellite glial contact enhances differentiation and maturation of human iPSC-derived sensory neurons
Stem Cell Reports 2025cited by 5position: contributordoi
CNSC-81. H3G34-MUTANT DIFFUSE HEMISPHERIC GLIOMAS CONTAIN CELLULAR NICHES OF GABAERGIC INTERNEURON-LIKE CELLS WITH DUAL FREQUENCY AUTONOMOUS RHYTHMIC CALCIUM ACTIVITY
Neuro-Oncology 2025cited by 0position: middledoi
Developmental basis of SHH medulloblastoma heterogeneity
Nature Communications 2024cited by 27position: middledoi
Developmental basis of SHH medulloblastoma heterogeneity.
2024cited by 23position: contributordoi
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma
Acta Neuropathologica Communications 2024cited by 12position: middledoi
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma.
2024cited by 10position: contributordoi
Genome-wide CRISPR-Cas9 knockout screens identify DNMT1 as a druggable dependency in sonic hedgehog medulloblastoma.
2024cited by 8position: contributordoi
Supplemental Table 1 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 6 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 3 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 6 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 3 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 4 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 5 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 2 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 5 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 1 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplementary Figures from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 4 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplementary Figures from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplemental Table 2 from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplementary Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
Supplementary Data from A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH Medulloblastoma
2024cited by 0position: contributordoi
TMEM161B regulates cerebral cortical gyration, Sonic Hedgehog signaling, and ciliary structure in the developing central nervous system
Proceedings of the National Academy of Sciences 2023cited by 28position: middledoi
TMEM161B regulates cerebral cortical gyration, Sonic Hedgehog signaling, and ciliary structure in the developing central nervous system.
2023cited by 25position: contributordoi
Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN.
2022cited by 81position: contributordoi
An affinity for brainstem microglia in pediatric high-grade gliomas of brainstem origin
Neuro-Oncology Advances 2022cited by 4position: middledoi
Synthetic extracellular matrices and astrocytes provide a supportive microenvironment for the cultivation and investigation of primary pediatric gliomas.
2022cited by 3position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 31 papers (2019–2025)Grace H. Hwang · Harvard University21 papers (2019–2024)Hyuk-Soo Seo · Boston University20 papers (2020–2024) · 19 papers (2024–2024)Matthew G. Rees · Dimagi (United States)19 papers (2024–2024)Jennifer A. Roth · Dimagi (United States)19 papers (2024–2024)Lincoln Ombelets · California Institute of Technology19 papers (2024–2024)Sirano Dhe-Paganon · Boston University19 papers (2024–2024)Nathalie Y. R. Agar · Bruker (United States)19 papers (2024–2024)David A. Scott · Dana-Farber/Harvard Cancer Center19 papers (2024–2024)Sylwia A. Stopka · Dana-Farber Cancer Institute19 papers (2024–2024)Melissa Ronan · Dimagi (United States)19 papers (2024–2024)Georgia A. Dittemore · Harvard University19 papers (2024–2024)Alison Volkert · 19 papers (2024–2024)Thomas W. Gero · Dana-Farber Cancer Institute19 papers (2024–2024)Maria F. Pazyra-Murphy · Harvard University19 papers (2024–2024)Nizhoni Sutter · University of Washington19 papers (2024–2024)Mariella G. Filbin · Harvard University4 papers (2015–2025)Oded Behar · Hebrew University of Jerusalem3 papers (2015–2022) · 3 papers (2015–2021)